Neoadjuvant Therapy for Locally Advanced Low Rectal Cancer (SMARTi-RC01)

NCT07134101 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer (Diagnosis)

Interventions

DRUG: Serplulimab
DRUG: Bevacizumab
RADIATION: Short-Course Radioterapy
DRUG: Chemotherapy (CAPOX or capecitabine)

Sponsor

The First Affiliated Hospital with Nanjing Medical University